About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Aripiprazole in Adolescents With Schizophrenia

Aripiprazole in Adolescents With Schizophrenia

NCT00102063·55 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

Age

13–17

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Primary diagnosis of Schizophrenia 1

You may not be if

Patients diagnosed with schizoaffective disorder, major depressive disorder, delirium, or bipolar disorder

The record

StatusCompleted

PhasePhase 3

Taking part302

StartedJul 2004

UpdatedAug 10, 2012

Conditions

Where55

Local Institution
Birmingham, Alabama, United States
Local Institution
Little Rock, Arkansas, United States
Local Institution
Costa Mesa, California, United States